A new Scientific Statement from the Heart Failure Society of America (HFSA) challenges longstanding ambiguity in the classification and treatment of heart failure with mildly reduced ejection fraction ...

In a new research report, a team of scientists led by Johns Hopkins Medicine say people with severe obesity and a common type ...

In a new research report, a team of scientists led by Johns Hopkins Medicine say people with severe obesity and a common type ...

People with mildly reduced ejection fraction, a distinct group with unique needs, account for nearly one-quarter of HF cases.

EAT index measured by CMR may identify high-risk HFpEF patients and predict outcomes. Learn more about its role in risk ...

Most US veterans who have new heart failure with reduced ejection fraction do not receive all four classes of ...

New research shows that finerenone, a nonsteroidal MRA, significantly reduces worsening events in heart failure with preserved or mildly reduced ejection fraction, offering hope where few treatments ...

Objective: To provide an overview of heart failure with preserved ejection fraction (HFPEF), as well as its pathophysiology, diagnosis, and clinical evidence regarding its pharmacologic management.

LV myocardial strain reference values from CT reveal sex differences in healthy adults. Learn how this could refine cardiac ...

A Johns Hopkins-led study reports that severe obesity in people with heart failure with preserved ejection fraction (HFpEF) is linked to weakened contraction of heart muscle cells, but this defect may ...